Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Completed 4Terminated 1Recruiting 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 9Breast 4Head & Neck 3Genitourinary 3Other hematologic neoplasm 2Thoracic 1Sarcoma 1Other 1Lymphoid 1Classical hematology 1

Conditions

Breast Neoplasms 4Osteoporosis 1Myocardial Ischemia 1Malnutrition 1Heart Diseases 1Coronary Disease 1Colonic Neoplasms 1Cardiovascular Diseases 1Bone Diseases 1Anus Neoplasms 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Dietary Supplements × Breast × Clear all
NCT07199556 2025-10-03

DOLFLEX

Arafarma Group, S.A.

Phase NA Completed
30 enrolled
Breast

Breast Neoplasms

NCT07021378 2025-06-15

NESTLE

D'Or Institute for Research and Education

Phase NA Completed
16 enrolled
BreastGastrointestinal

Anus Neoplasms, Breast Neoplasms, Malnutrition

NCT05762042 2023-03-09

Comparison of the Efficacy and Tolerability of Femal Versus Placebo

Azienda Ospedaliera Ordine Mauriziano di Torino

Phase NA Completed
34 enrolled
Breast

Breast Neoplasms

NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡